Search
The transition of Value Research Online has been postponed to take care of some user concerns.
You are welcome to try out the new site at https://beta.valueresearchonline.com

Gufic Biosciences

Sector: Healthcare | Industry: Drugs & Pharma
R 62.45 -1.85  | -2.88% -29.87% 21.16 486.83
NSE Price: Dec 06, 15:56 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Dec 06, 15:56 62.45 -1.85 -2.88% 64.30 64.30 17,772 62.05 - 64.90
BSE Dec 06, 2019 62.55 -1.85 -2.87% 64.00 64.40 1,943 62.25 - 64.00
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 56,862 P/B: 5.76 NSE Code: GUFICBIO
52-Week Range: R 51.05 - 99.10 Dividend Yield: 0.08% BSE Code: 509079
TTM EPS: R 2.96 Book Value: R 10.85 Face Value: R 1
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 37
Price Graph
  • Procter & Gamble Health (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Value Research Stock Advisor now has 37 stock recommendations and new ones are added every month.
Thousands of our members are using the current market conditions to buy great stocks at low prices.

Membership of this premium service is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Gufic Biosciences -33.14 -10.71 -4.72 -29.36 10.87 30.50 25.51
S&P BSE Small Cap* -8.51 -0.49 7.68 -6.16 3.56 3.23 5.53
S&P BSE Healthcare* -3.24 2.16 4.31 -2.91 -4.93 -2.03 10.33
Company's return has been calculated on basis of BSE's price.
As on Dec 06, 2019
*As on Dec 05, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 14.79 20.16 23.31
Net Profit 33.17 44.15 38.77
EPS 33.17 43.86 38.59
Book Value 39.18 30.16 23.36
Average
Operating Margin 14.30 12.62 11.54
Net Margin 6.18 5.06 4.30
Return on Networth 33.89 31.74 26.96
Return on Investment 29.65 29.34 26.13
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -6.89 -6.92 -6.03
Operating Profit -10.34 -9.16 -25.34
Net Profit -36.82 -30.44 -28.45
EPS -36.82 -30.44 -28.45
TTM
Revenue -1.76 4.40 2.06
Operating Profit -2.20 16.01 5.58
Net Profit -7.56 34.46 5.69
EPS -7.56 34.28 5.58
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Gufic Biosciences 486.83 357.62 23.01 6.33 33.89 5.76 21.16
Astrazeneca Pharma India 6,631.63 818.54 74.85 8.97 20.03 20.12 88.60
Procter & Gamble Health 7,064.70 894.23 835.89 14.21 73.79 9.06 52.71
Fund Houses invested in the stock
Fund Sep-19 Jun-19 Mar-19 Dec-18 Sep-18
SBI Mutual Fund 4.818 4.818 5.169 6.485 7.166
ICICI Prudential Mutual Fund 2.980 3.025 3.025 1.968 1.095
Figures given above are % of equity capital
News & Announcements
Contact Information

Company: Gufic Biosciences Ltd.

Address: Shop - 37, First Floor, Kamala Bhavan I I, Swami Nityanand Road, Andheri East, Mumbai, Maharashtra - 400069

Email: [email protected]

Website: www.gufic.com

Registrar & Transfer Agent: Link Intime India Pvt Ltd.

Address: C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra, C 101, 247 Park, LBS Marg, Vikhroli (West) | Phone: 91-022-49186000/49186270 | Fax: 91-022-49186060

Email: [email protected]

Website: www.linkintime.co.in

Essential checks
Altman Z-Score
3.79
Piotroski F-Score
7
Modified C-Score
5
5-Years Price to Earnings
21.16
5-Years Price to Book
5.76
Earnings Yield
EBIT / Enterprise value
8.04%
PEG
Price / Earnings to growth ratio
0.57
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,652.10 -2.42%
Eris Lifesciences R476.35 +7.39%
FDC R206.25 +4.14%
Granules India R121.50 -4.44%
JB Chemicals & Pharma R403.25 +0.41%
Laurus Labs R340.20 -1.05%
Procter & Gamble Health R4,255.45 -1.09%
Strides Pharma Science R378.05 -0.49%
Sun Pharma Adv. Research R153.80 -1.51%
Suven Life Sciences R279.55 +2.46%
As on Dec 06, 15:59